Point72 Asset Management »

Cullinan Oncology shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.7M 360k 10.35
2023-09-30 $2.0k 224 9.05
2023-06-30 $22k 2.0k 10.76

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Blue Owl Capital Holdings
State Street Corporation
Citadel Advisors
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Boothbay Fund Management
Siren

View all funds holding Cullinan Oncology